explore -WSS

explore

author：fashion 2025-09-30 22:05:16 - browse：61577

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： There should be a 'Moonshot' or 'Warp Speed' for rare diseases

focus

hotspot

WSS

Neuroscience renaissance leads to new crop of psychiatric drugs

'The Exorcist' director William Friedkin dead at 87

Study fuels hope CAR

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

leisure time

explore

focus

At least 13 dead in Texas as scorching temps continue

Medicare isn't yet testing food as medicine

Virginia high school admissions case could be legal follow

NYC plans to house migrants on an island in the East River

Trump demands the U.S. pay no more for drugs than other countries … again

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Childhood vaccination ad campaign launches in the U.K.

focus

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Children’s Hospital revives plan for pedestrian bridge

Pfizer is about to make a big push in cancer. Will investors listen?

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

CDC advisory group OKs chikungunya vaccine

Ohio train derailment: Experts on toxic chemical risks

knowledge

focus

hotspot

entertainment